We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,863
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THRY icon
4001
Thryv Holdings
THRY
$96M
$13K ﹤0.01%
439
+152
+53% +$4.77K
TYRA icon
4002
Tyra Biosciences
TYRA
$1.51B
$13K ﹤0.01%
1,243
+280
+29% +$3.32K
USXF icon
4003
iShares ESG Advanced MSCI USA ETF
USXF
$1.52B
$13K ﹤0.01%
+371
New +$13.2K
VHI icon
4004
Valhi
VHI
$459M
$13K ﹤0.01%
446
+69
+18% +$1.88K
VTYX
4005
DELISTED
Ventyx Biosciences
VTYX
$13K ﹤0.01%
961
+414
+76% +$5.53K
XAIR icon
4006
Beyond Air
XAIR
$5.6M
$13K ﹤0.01%
5
+2
+67% +$5.88K
XLB icon
4007
State Street Materials Select Sector SPDR ETF
XLB
$8.6B
$13K ﹤0.01%
290
-148,242
-100% -$6.32M
NAGE
4008
Niagen Bioscience
NAGE
$239M
$13K ﹤0.01%
5,270
+740
+16% +$2.02K
LGF.A
4009
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$13K ﹤0.01%
778
+25
+3% +$391
WINV
4010
DELISTED
WinVest Acquisition Corp. Common Stock
WINV
$13K ﹤0.01%
1,286
-1,456
-53% -$14.4K
PSTX
4011
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$13K ﹤0.01%
3,010
+1,426
+90% +$6.43K
FUV
4012
DELISTED
Arcimoto, Inc. Common Stock
FUV
$13K ﹤0.01%
97
-128
-57% -$16.6K
AKU
4013
DELISTED
Akumin Inc
AKU
$13K ﹤0.01%
11,547
+7,937
+220% +$9.86K
SAL
4014
DELISTED
Salisbury Bancorp, Inc.
SAL
$13K ﹤0.01%
+486
New +$13.4K
BOXD
4015
DELISTED
Boxed, Inc.
BOXD
$13K ﹤0.01%
1,244
+134
+12% +$1.36K
EVOP
4016
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$13K ﹤0.01%
567
-313
-36% -$7.44K
QUMU
4017
DELISTED
Qumu Corp.
QUMU
$13K ﹤0.01%
7,455
-371
-5% -$692
HYRE
4018
DELISTED
HyreCar Inc. Common Stock
HYRE
$13K ﹤0.01%
5,450
+983
+22% +$3.04K
NH
4019
DELISTED
NantHealth, Inc
NH
$13K ﹤0.01%
1,193
+596
+100% +$7.6K
LGV
4020
DELISTED
Longview Acquisition Corp. II
LGV
$13K ﹤0.01%
1,295
+131
+11% +$1.28K
AMPI.U
4021
DELISTED
Advanced Merger Partners Inc Units
AMPI.U
$13K ﹤0.01%
+1,314
New +$12.9K
TEN
4022
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$13K ﹤0.01%
719
-288
-29% -$4.13K
PAQC
4023
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
$13K ﹤0.01%
1,277
+1,130
+769% +$11.1K
CNVY
4024
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$13K ﹤0.01%
2,029
+671
+49% +$4.43K
CNTQU
4025
DELISTED
Chardan NexTech Acquisition 2 Corp. Unit
CNTQU
$13K ﹤0.01%
1,267
-200
-14% -$2.05K
159 160
161
162 163

Similar funds

AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 44.45% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $4.11B AUM 27.59% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,863 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.